ung disease prevention encompasses strategies aimed at reducing the risk of both acute and chronic respiratory conditions, preserving lung function, and enhancing overall respiratory health. Environmental exposures, smoking, occupational hazards, air pollution, and infections are major contributors to lung morbidity. Preventive measures target these risk factors through lifestyle modification, early detection, immunization, and workplace safety interventions. Educating individuals about the harmful effects of tobacco, secondhand smoke, and environmental pollutants is critical to reducing the incidence of conditions such as chronic obstructive pulmonary disease, lung cancer, and asthma. Nutritional optimization, regular physical activity, and respiratory hygiene practices further support lung resilience and immunity.
Routine screening programs, including spirometry for at-risk populations, facilitate early detection of obstructive or restrictive lung conditions. Vaccinations against influenza, pneumococcus, and other respiratory pathogens minimize infection-related exacerbations. Occupational health regulations, clean indoor air policies, and reduction of environmental pollutants protect communities and vulnerable populations. Targeted interventions for high-risk groups, including children, the elderly, and individuals with pre-existing respiratory conditions, ensure tailored preventive strategies. Multidisciplinary collaboration among public health officials, clinicians, and community organizations is essential to implement and monitor these initiatives. By integrating individual, community, and policy-level measures, lung disease prevention efforts reduce disease burden, improve quality of life, and support long-term respiratory wellness across diverse populations.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation